BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook

Published: Aug 08, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Aug. 8, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders, today reported second quarter product revenues of $1.0 million, a 72% increase from product revenues reported in the second quarter of 2012, and a net loss of $4.8 million, a 25% reduction from the net loss reported in the second quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news